Check out our most popular compounded medications! Get Started
Phenylpropanolamine HCl 12.5 mg Oral Capsules are a solid dosage form designed for veterinary use. Each capsule consists of two halves, either gelatin or vegetarian-based, that encapsulate a precise 12.5 mg dose of the active ingredient, Phenylpropanolamine HCl. This medication is specifically formulated for easy oral administration to pets, ensuring accurate dosing and patient compliance.
These capsules are commonly prescribed to treat conditions such as urinary incontinence in dogs, particularly those resulting from urethral sphincter hypotonus. Phenylpropanolamine HCl works by tightening the bladder sphincter muscle, thereby helping to control urine leakage. The use of this medication should be under the guidance of a veterinarian, and it is important to follow the prescribed dosage and administration instructions to ensure the safety and efficacy of the treatment.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Phenylpropanolamine HCl 12.5 mg Oral Capsules are a solid dosage form specifically designed for veterinary use. These capsules consist of two halves, either made from gelatin or a vegetarian alternative, which encapsulate the active pharmaceutical ingredient, Phenylpropanolamine HCl. This design ensures that the medication is delivered in a precise 12.5 mg dose, which is critical for maintaining the efficacy and safety of the treatment. The capsules are easy to administer to animals, as they can be swallowed whole, avoiding the need for compounding into a palatable form at the time of administration.
Phenylpropanolamine (PPA) is primarily used in veterinary medicine for the management of urinary incontinence in dogs, particularly those with urethral sphincter hypotonus. It acts as a sympathomimetic agent, stimulating alpha-adrenergic receptors and causing the constriction of the urethral sphincter, thereby helping to control urinary leakage. PPA may also be used as a decongestant as it can reduce swelling of the nasal mucosa. However, its use for this purpose is less common in veterinary practice.
The precise dosing provided by the 12.5 mg capsules is essential to avoid potential side effects, which can include increased blood pressure, restlessness, irritability, and appetite loss. As with all medications, it is crucial to follow the dosing instructions provided by the veterinarian and to monitor the animal for any adverse reactions. Additionally, PPA is not suitable for all animals, and its use is contraindicated in pets with certain pre-existing conditions or those taking certain medications.
At Bayview Pharmacy, we are committed to providing high-quality compounded medications to meet the specific needs of our veterinary patients. Our team of knowledgeable compounding pharmacists is available to answer any questions or concerns you may have regarding Phenylpropanolamine HCl 12.5 mg Oral Capsules or any other medication needs. Please do not hesitate to reach out to us for further information or guidance.
Phenylpropanolamine HCl (PPA) is a sympathomimetic agent that has been used in veterinary medicine to treat conditions such as urinary incontinence in dogs by increasing the tone of the urethral sphincter. However, it is important to be aware of potential drug interactions when administering PPA to ensure the safety and well-being of the animal.
PPA should be used with caution in animals that are concurrently receiving monoamine oxidase inhibitors (MAOIs) such as selegiline or amitraz, as these can potentiate the effects of sympathomimetics and may lead to severe hypertension or other cardiovascular complications. Similarly, caution is advised when PPA is used with other sympathomimetic drugs, including decongestants and appetite suppressants, due to the risk of additive effects and increased blood pressure.
Concurrent use of PPA with tricyclic antidepressants (TCAs) like amitriptyline or clomipramine may also lead to increased sympathomimetic effects or cardiac arrhythmias. If PPA is used with antihypertensive drugs, such as beta-blockers or ACE inhibitors, there may be a reduced efficacy of these medications, potentially leading to poor blood pressure control.
Animals receiving PPA in combination with anesthetic agents, particularly those that may depress the cardiovascular system, should be closely monitored as PPA may counteract the effects of some anesthetics. Additionally, the use of PPA with nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal ulceration or renal dysfunction, and appropriate monitoring is recommended.
It is also important to consider the potential for interactions with other over-the-counter medications or dietary supplements that the animal may be taking. For example, ephedrine or other herbal supplements with sympathomimetic properties could interact with PPA and lead to adverse effects.
Due to the risk of drug interactions and the potential for adverse effects, it is crucial for prescribers to thoroughly review the animal's current medication list before prescribing PPA. Additionally, pet owners should be advised to inform the veterinary team of any other medications or supplements their pet is receiving. If you have any questions or concerns regarding the use of Phenylpropanolamine HCl 12.5 mg Oral Capsules or potential drug interactions, please reach out to us at Bayview Pharmacy for further assistance.
Phenylpropanolamine HCl, the active ingredient in these 12.5 mg oral capsules, is a sympathomimetic agent that works by stimulating the alpha-adrenergic receptors in the body. When administered, it causes vasoconstriction, which can lead to an increase in blood pressure. Additionally, it has a moderate stimulating effect on the beta-adrenergic receptors, which can lead to relaxation of the smooth muscle in the bronchi and an increase in heart rate and contractility. In veterinary medicine, phenylpropanolamine is commonly used for the management of urinary incontinence in dogs, particularly due to its ability to increase the tone of the urethral sphincter.
The formulation of these capsules involves the precise measurement of phenylpropanolamine HCl to ensure each capsule contains the correct dosage of 12.5 mg. The active ingredient is then encapsulated within two halves of either gelatin or vegetarian shells, depending on the preference or dietary restrictions of the pet. These solid dosage forms are designed to be easy to administer to animals, ensuring that the medication is delivered in a form that is palatable and can be swallowed without difficulty. The encapsulation also protects the active ingredient from degradation due to environmental factors such as light and moisture, thereby maintaining its efficacy until ingestion.
Upon oral administration, the capsule shell dissolves in the animal's gastrointestinal tract, releasing the phenylpropanolamine HCl for absorption. The medication then enters the systemic circulation and exerts its therapeutic effects. For the treatment of urinary incontinence, the increased urethral tone helps to prevent the involuntary leakage of urine. It is important for prescribers to consider the appropriate dosage and monitor the animal for any potential side effects, such as hypertension, restlessness, or irritability, which can occur due to the sympathomimetic activity of the drug.
For patients and prescribers considering the use of Phenylpropanolamine HCl 12.5 mg Oral Capsules for veterinary use, it is crucial to understand the mechanism of action and the conditions it is intended to treat. This medication should be used under the guidance of a veterinarian, and it is essential to follow the prescribed dosage regimen to ensure the safety and well-being of the animal. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and answer any queries you may have.
While Phenylpropanolamine HCl 12.5 mg oral capsules are primarily used as a veterinary medication to treat urinary incontinence in dogs by increasing the tone of the urethral sphincter, it is important to note that there may be additional applications for this medication in veterinary medicine. For example, Phenylpropanolamine, sometimes abbreviated as PPA, has also been used to manage symptoms of nasal congestion due to its vasoconstrictive properties when it was available for human use. This effect can potentially benefit animals who are suffering from conditions that lead to a congested nasal passage.
Furthermore, Phenylpropanolamine is a sympathomimetic agent, which means it mimics the effect of sympathetic nervous system stimulation. This can lead to an increase in blood pressure and heart rate, making it a medication that requires careful monitoring and judicious use. There have been instances where Phenylpropanolamine has been used off-label to treat conditions associated with hypotension or low blood pressure in dogs. However, such uses would be considered off-label and warrant careful consideration by the prescribing veterinarian.
It's also important to note that the use of Phenylpropanolamine in small animal medicine must be approached with caution due to its potential side effects and the fact that it has been withdrawn from human markets in some countries due to concerns over increased risk of hemorrhagic stroke in women. This underscores the necessity for veterinarians to weigh the benefits against the risks in the context of a pet's specific health condition when considering this medication.
The gelatin or vegetarian capsule formulation of Phenylpropanolamine HCl 12.5 mg provides a solid dosage form that is easy to administer to animals, helps mask the taste of the medication, and ensures a precise dose is delivered each time. The choice of capsule material can cater to pet owners with preferences for non-animal derived products, while still maintaining the integrity of the encapsulated medication.
If there are any further questions or a need for additional information regarding the usage of Phenylpropanolamine HCl 12.5 mg oral capsules for veterinary use, both patients and prescribers are encouraged to reach out to us at Bayview Pharmacy. Our team is well-equipped to provide you with the necessary guidance and support as you explore the potential uses and benefits of this medication for your veterinary patients.
Phenylpropanolamine HCl, commonly known as PPA, is a sympathomimetic agent used primarily in veterinary medicine to treat urinary incontinence in dogs by tightening the muscles of the urinary sphincter.
Each oral capsule contains 12.5 mg of Phenylpropanolamine HCl.
These capsules are to be given orally to pets, typically swallowed whole. They are designed to be easy for animals to ingest.
It is often recommended to administer these capsules with food to minimize the risk of stomach upset, but follow the specific instructions provided by your veterinarian.
No, the capsules should not be opened or crushed. They are designed to release the medication at the correct rate and opening them could alter the effectiveness of the drug.
As with any medication, Phenylpropanolamine HCl may cause side effects. Common ones include restlessness, increased heart rate, increased blood pressure, and loss of appetite. If you notice any severe side effects or changes in your pet's behavior, contact your veterinarian.
Store the capsules in a cool, dry place away from light and moisture. Keep them out of reach of children and pets.
If you miss a dose, give it as soon as you remember. However, if it's almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not give two doses at once to catch up.
Duration of treatment varies depending on the pet's condition and response to therapy. Your veterinarian will determine the appropriate treatment duration.
While primarily used for dogs, your veterinarian will decide if it is appropriate for other species. Always consult with your veterinarian before using any medication for a species for which it was not prescribed.
Yes, discuss your pet's complete medical history, including any other medications or supplements they are taking, as well as any pre-existing medical conditions. This information will help your veterinarian determine if Phenylpropanolamine HCl is safe for your pet.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
